Ternes, Luke
Dane, Mark http://orcid.org/0000-0003-3742-9866
Gross, Sean
Labrie, Marilyne http://orcid.org/0000-0003-3957-5533
Mills, Gordon
Gray, Joe
Heiser, Laura http://orcid.org/0000-0003-3330-0950
Chang, Young Hwan http://orcid.org/0000-0001-8764-1959
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01 CA217842, 1U01 CA253472-01A1, U54HG008100, U54CA209988, U2CCA233280, U54HG008100, U54CA209988, U01 CA224012, R01 CA253860)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 7 July 2021
Accepted: 7 March 2022
First Online: 23 March 2022
Competing interests
: L.T., M.D., S.G., M.L., L.H., and Y.H.C. have no competing interests. G.M. is a SAB/Consultant for the following: Abbvie, Amphista, AstraZeneca, Chrysallis Biotechnology, GSK, Ellipses Pharma, ImmunoMET, Ionis, Lilly, Medacorp, PDX Pharmaceuticals, Signalchem Lifesciences, Symphogen, Tarveda, Turbine, Zentalis Pharmaceuticals; has licensed technology in the following: HRD assay to Myriad Genetics, DSP patents with Nanostring; and G.M. has stock, financial, or other interests in the following: Catena Pharmaceuticals, ImmunoMet, SignalChem, Tarveda, Turbine. J.G. has licensed technologies to Abbott Diagnostics; has ownership positions in Convergent Genomics, Health Technology Innovations, Zorro Bio, and PDX Pharmaceuticals; serves as a paid consultant to New Leaf Ventures; has received research support from Thermo Fisher Scientific (formerly FEI), Zeiss, Miltenyi Biotech, Quantitative Imaging, Health Technology Innovations, and Micron Technologies.